510(k) Report

510(k) · Cleared

Cleared

Merogel Nasal Dressing and Sinus Stent

K982731510(k) TraditionalCleared Feb 2, 1999181-day reviewClass I21 CFR 874.4100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Xomed, Inc. · EMX Balloon, Epistaxis

Cleared on Feb 2, 1999 after a 181-day review. The FDA summary names its predicate without a number. 49 later devices descend from it.

Decided
Feb 2, 1999
Review
181 days
Class
Class I
Product code
EMX
Recalls
None
Predicates
0

49 later devices descend from it, 7 citing it directly.

Descendants, by year cleared 2001: 1 descendant cleared2000: 1 descendant cleared2007: 5 descendants cleared2006: 2 descendants cleared2005: 2 descendants cleared2013: 2 descendants cleared2016: 1 descendant cleared2003: 1 descendant cleared2008: 3 descendants cleared2014: 6 descendants cleared2012: 4 descendants cleared2020: 1 descendant cleared2009: 2 descendants cleared2018: 3 descendants cleared2010: 2 descendants cleared2022: 1 descendant cleared2017: 2 descendants cleared2011: 1 descendant cleared2015: 2 descendants cleared2019: 4 descendants cleared2024: 1 descendant cleared2021: 1 descendant cleared2023: 1 descendant cleared1995200020052010201520202025
  1. This deviceK982731 Merogel Nasal Dressing and Sinus StentXomed, Inc. · 1999
  2. Descendant · cites it directly · 47 of its ownK012532 Sepragel SinusGenzyme Corp. · 2001
  3. Descendant · cites it directly · 35 of its ownK993362 HylasineBiomatrix, Inc. · 2000
  4. Descendant · 2 generations on · 29 of its ownK033666 HemadermMedafor, Inc. · 2003
  5. Descendant · 3 generations on · 28 of its ownK070211 Traumarrest and Bleedarrest Hemostatic Particles and FoamHemostasis, LLC · 2007
  6. Descendant · 4 generations on · 19 of its ownK072900 Excelarrest FoamHemostasis, LLC · 2007

Showing 5 of 49 descendants. See all descendants

Descendants cleared per year

2000: 12001: 12003: 12005: 22006: 22007: 52008: 32009: 22010: 22011: 12012: 42013: 22014: 62015: 22016: 12017: 22018: 32019: 42020: 12021: 12022: 12023: 12024: 1
2000high 6 (2014) · low 0 (2002)2026

Most influential descendants

Showing 5 of 49 · See all
  • K012532Sepragel SinusGenzyme Corp. · 2001 · cites it directly47descendants
  • K993362HylasineBiomatrix, Inc. · 2000 · cites it directly35descendants
  • K033666HemadermMedafor, Inc. · 2003 · 2 generations on29descendants
  • K070211Traumarrest and Bleedarrest Hemostatic Particles and FoamHemostasis, LLC · 2007 · 3 generations on28descendants
  • K072900Excelarrest FoamHemostasis, LLC · 2007 · 4 generations on19descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K982731Merogel Nasal Dressing and Sinus StentXomed, Inc.1999—
+1K012532Sepragel SinusGenzyme Corp.2001—
+1K993362HylasineBiomatrix, Inc.2000—
+2K033666HemadermMedafor, Inc.2003—
+3K070211Traumarrest and Bleedarrest Hemostatic Particles and FoamHemostasis, LLC2007—
+4K072900Excelarrest FoamHemostasis, LLC2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200010
200110
200310
200520
200620
200750
200830
200920
201020
201110
201240
201320
201460
201520
201610
201720
201830
201940
202010
202110
202210
202310
202410
FIG. 1 — Lineage of K982731, 1999–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in EMX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new EMX device

  1. #1 K220326 PosiSep X BAM Hemostat Dressing/Intranasal…score 4.3 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Merocel® Sinus-Pak™
Named without a submission number
—
*—Merocel® Standard Nasal Dressing
Named without a submission number
—

What descends from it? (49)

See all 49

7 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K012532Sepragel SinusGenzyme Corp.200147
K993362HylasineBiomatrix, Inc.200035
K052099Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V.,200517
K063308Advacoat Sinus Gel, Model 9100, Adva Sinus Stent, Model 9200Carbylan Biosurgery20064
K070496Advacoat Sinus Gel and StentCarbylan Biosurgery20073
K122494Posisep and Posisep X Hemostat Dressing/Intranasal SplintHemostasis, LLC20132
K160101SinuBandBioinspire Technologies, Incorporated20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K012532 (Genzyme Corp., 2001) has gone furthest, with 47 descendants of its own.

How does its category compare?

All EMX devices

EMX Balloon, Epistaxis: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · EMX

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · EMX

Too few EMX 510(k)s in any year since 2007 to give a median.

Recalls per year · EMX

No recall names EMX since 2007.

Adverse event reports per year · EMX

16in 2025

2007: 32008: 32009: 32010: 32011: 102012: 12013: 32014: 12016: 12018: 32019: 122020: 52021: 22023: 32024: 122025: 16
2007high 16 (2025) · low 0 (2015)2025

MAUDE reports naming product code EMX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20080—03
20090—03
20100—03
20110—010
20120—01
20130—03
20140—01
20150—00
20160—01
20170—00
20180—03
20190—012
20200—05
20210—02
20221—00
20230—03
20240—012
20250—016
20260—0—

What is it indicated for?

Xomed MeroGel™ Nasal Dressing and Sinus Stent is intended for use in the nasal/sinus cavities as a space occupying dressing and/or stent, to separate mucosal surfaces and help control minimal bleeding following surgery.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K982731: Merogel Nasal Dressing and Sinus Stent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K982731

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026